Howard Financial Services’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$482K Buy
715
+134
+23% +$79.6K 0.05% 135
2026
Q2
$291K Sell
581
-144
-20% -$69.1K 0.03% 181
2026
Q1
$356K Buy
725
+175
+32% +$95K 0.04% 158
2025
Q4
$319K Buy
550
+52
+10% +$29.4K 0.04% 154
2025
Q3
$242K Buy
+498
New +$232K 0.03% 164
2025
Q2
– Sell
-671
Closed -$334K – 199
2025
Q1
$334K Sell
671
-95
-12% -$51.5K 0.05% 132
2024
Q4
$399K Buy
766
+432
+129% +$238K 0.05% 119
2024
Q3
$207K Buy
+334
New +$198K 0.03% 158
2023
Q4
– Sell
-458
Closed -$232K – 161
2023
Q3
$232K Buy
+458
New +$244K 0.05% 130

Other funds holding TMO

Howard Financial Services's TMO Position: Q3 2026 in Review

Howard Financial Services increased its Thermo Fisher Scientific (TMO) stake by 23% in Q3 2026, buying an estimated $79.6K and bringing the position to 715 shares worth $482K. The position accounts for 0.05% of the portfolio, ranked #135.

Howard Financial Services first reported a position in TMO in Q3 2023 and has held it in 9 quarters since. 2,806 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Howard Financial Services held 715 shares of Thermo Fisher Scientific worth $482K as of Q3 2026.
  • Howard Financial Services bought 134 Thermo Fisher Scientific shares in Q3 2026, an estimated $79.6K.
  • Thermo Fisher Scientific made up 0.05% of Howard Financial Services's portfolio in Q3 2026, its #135 holding.
  • Howard Financial Services first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 9 quarters since.
  • 2,806 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Howard Financial Services's 13F filing for Q3 2026, filed 15 Oct 2026.